Observational Study on Metals and Pulmonary Hypertension
This observational study is looking at the levels of different metals, including heavy metals like cadmium and lead, and essential metals like iron and zinc, in people with pulmonary arterial hypertension (PAH) and healthy volunteers. Researchers want to understand if imbalances in these metal levels contribute to PAH and its progression. They will measure 31 different metal levels in blood and urine samples. The study aims to enroll 110 participants, including 50 PAH patients and 10 healthy volunteers who are similar in age and gender. The study is currently recruiting participants.
- Study design
- This is an observational study planning to enroll 110 participants, including 50 PAH patients and 10 healthy controls.
- What's involved
- If you have PAH, you will have blood and urine samples taken at your regular clinic visits, which occur at least every 6 months. Healthy volunteers will also provide blood and urine samples.
- Compensation
- Not stated in the trial record.
- Follow-up
- Metal levels will be measured at up to 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Metal levels in control and pulmonary hypertension groupsup to 12 months
Metal levels in control and pulmonary hypertension groups